Ectodermal Dysplasia 1, Anhidrotic: Clinical Trials

2 trials for Ectodermal Dysplasia 1, Anhidrotic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 recruiting. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Recruiting 1

Follow Ectodermal Dysplasia 1, Anhidrotic: new trials by email Literature Review of Ectodermal Dysplasia 1, Anhidrotic trials Research Report on Ectodermal Dysplasia 1, Anhidrotic

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Intraamniotic Administrations of ER004 to Male Subjects With X-linked Hypohidrotic Ectodermal Dysplasia
ER004 - X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED)
Phase 2RecruitingEspeRare Foundation202022-04-262025-04-30
Phase 2 Study to Evaluate Safety, Pharmacokinetics, Immunogenicity and Pharmacodynamics/Efficacy of EDI200 in Male Infants With X-Linked Hypohidrotic Ectodermal Dysplasia (XLHED)
EDI200 - X-Linked Hypohidrotic Ectodermal Dysplasia
Phase 2CompletedEdimer Pharmaceuticals62013-04-012016-01-20

Broader conditions

Abnormalities, Multiple (2)  ·  Congenital Abnormalities (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Ectodermal Dysplasia (2)  ·  Genetic Diseases, Inborn (2)  ·  Genetic Diseases, X-Linked (2)  ·  Skin Abnormalities (2)  ·  Skin Diseases (2)  ·  Skin Diseases, Genetic (2)  ·  Skin and Connective Tissue Diseases (2)

Interventions

Fc-EDA (1)

Sponsors

Edimer Pharmaceuticals (1)  ·  EspeRare Foundation (1)

Countries

France (2)  ·  Germany (2)  ·  Italy (2)  ·  United Kingdom (2)  ·  United States (2)  ·  Spain (1)

Top investigators

Holm Schneider, MD (1)  ·  Kenneth Huttner, MD, PhD (1)